Ganagliflozin Proline
脯氨酸加格列净
Report date: 2026/04/26 20:00:14
NME
Base Information
Drug NameGanagliflozin Proline
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2024/01/16
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShandong Xuanzhu Pharmaceutical Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesJilin Huisheng Biopharmaceutical Co Ltd
Inactive CompaniesShandong Xuanzhu Pharmaceutical Technology Co LtdSihuan Pharmaceutical Holdings Group LtdBeijing Sihuan Pharmaceutical Co Ltd
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A